% alzhub.org topic: disease-modifying-therapies
% Source: https://alzhub.org/topic/disease-modifying-therapies
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{nakamura2026-42982982,
  author  = {Nakamura, K. and Sekijima, Y.},
  title   = {{Clinical genetics and genetic counseling in the era of disease-modifying therapies for dementia: lessons from Japan}},
  journal = {Journal of human genetics},
  year    = {2026},
  doi     = {10.1038/s10038-026-01526-2},
  pmid    = {42982982},
  url     = {https://doi.org/10.1038/s10038-026-01526-2}
}

@article{padovani2026-42850455,
  author  = {Padovani, A. and Altini, M. and Bellelli, G. and Bozzali, M. and Brignoli, O. and Cagnin, A. and Cherubini, A. and Iannacci, M. and others},
  title   = {{Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus}},
  journal = {Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology},
  year    = {2026},
  doi     = {10.1007/s10072-026-09452-z},
  pmid    = {42850455},
  url     = {https://doi.org/10.1007/s10072-026-09452-z}
}

@article{sato2024-39251217,
  author  = {Sato, K. and Iwatsubo, T.},
  title   = {{[Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease]}},
  journal = {Brain and nerve = Shinkei kenkyu no shinpo},
  year    = {2024},
  doi     = {10.11477/mf.1416202723},
  pmid    = {39251217},
  url     = {https://doi.org/10.11477/mf.1416202723}
}

@article{frisoni2020-32815289,
  author  = {Frisoni, G. B. and Molinuevo, J. L. and Altomare, D. and Carrera, E. and Barkhof, F. and Berkhof, J. and Delrieu, J. and others},
  title   = {{Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1002/alz.12132},
  pmid    = {32815289},
  url     = {https://doi.org/10.1002/alz.12132}
}

@article{imbimbo2020-32657175,
  author  = {Imbimbo, B. P. and Lozupone, M. and Watling, M. and Panza, F.},
  title   = {{Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives}},
  journal = {Expert opinion on investigational drugs},
  year    = {2020},
  doi     = {10.1080/13543784.2020.1795127},
  pmid    = {32657175},
  url     = {https://doi.org/10.1080/13543784.2020.1795127}
}

@article{panza2019-30973276,
  author  = {Panza, F. and Imbimbo, B. P. and Lozupone, M. and Greco, A. and Seripa, D. and Logroscino, G. and Daniele, A. and Colosimo, C.},
  title   = {{Disease-modifying therapies for tauopathies: agents in the pipeline}},
  journal = {Expert review of neurotherapeutics},
  year    = {2019},
  doi     = {10.1080/14737175.2019.1606715},
  pmid    = {30973276},
  url     = {https://doi.org/10.1080/14737175.2019.1606715}
}